SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-18-001616
Filing Date
2018-02-14
Accepted
2018-02-14 10:44:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 d7821415_13g-a.htm SC 13G/A 108763
  Complete submission text file 0000919574-18-001616.txt   110316
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Subject) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: SC 13G/A | Act: 34 | File No.: 005-87755 | Film No.: 18608601
SIC: 2834 Pharmaceutical Preparations

Mailing Address 510 MADISON AVENUE, 22ND FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 22ND FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A